Physician profile
Robert Todd Seabrook
NPI 1720289424
$11,714.89
in general payments reported to CMS, 2019-2025
16 companies · $5,901 in 2025
The $5,901 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $23.40 · 2023: $71.36 · 2024: $5,603 · 2025: $5,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,351 · Travel and Lodging: $4,185 · Education: $37.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,351.19 |
| Travel and Lodging | $4,185.48 |
| Education | $37.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,266.97 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $3,161.24 | 2024-2025 | Proclaim, Eterna, Axium |
| Boston Scientific Corporation | $2,076.59 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Spinal Simplicity, LLC | $1,368.65 | 2024-2025 | Ha Minuteman G3-R, Patriot Si |
| Nalu Medical, INC. | $988.57 | 2025 | Nalu Neurostimulation System |
| Nevro Corp. | $343.76 | 2024 | Senza |
| Averitas Pharma INC. | $95.83 | 2025 | Qutenza |
| Merck Sharp & Dohme LLC | $93.39 | 2023-2024 | Bridion |
| Convatec INC. | $63.07 | 2025 | |
| Globus Medical, INC. | $58.34 | 2025 | Senza, Vyrsa V1 |
| Si-Bone, INC. | $47.27 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $42.04 | 2022-2023 | Iovera, Exparel |
| Biotronik Nro, INC. | $41.72 | 2025 | Prospera |
| Avanos Medical | $34.33 | 2024 | Coolief* Cooled Radiofrequency |
| Coopersurgical, INC. | $19.49 | 2024 | Insorb |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $13.63 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Seabrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.